Promoting exercise after a cancer diagnosis: easier said than done

Por Hudis, C A, Jones, L
Publicado em 2014

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

Por Ruddy, K. J., Pitcher, B. N., Archer, L. E., Cohen, H. J., Winer, E. P., Hudis, C. A., Muss, H. B., Partridge, A. H.
Publicado em 2012

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

Por Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V. F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R. H., Matera, J., Azarnia, N., Hudis, C. A., Rozencweig, M.
Publicado no Ann Oncol (2014)

Corrections to “Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer”

Por Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V.F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R.H., Matera, J., Azarnia, N., Hudis, C.A., Rozencweig, M.
Publicado no Ann Oncol (2019)

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

Por Fornier, M. N., Morris, P. G., Abbruzzi, A., D'Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A. D., Sklarin, N., Chang, J., Norton, L., Hudis, C. A.
Publicado no Ann Oncol (2011)

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Por Morris, P.G., Rota, S, Cadoo, K, Zamora, S, Patil, S, D’Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A.D., Sklarin, N., Norton, L, Hudis, C.A., Fornier, M.N.
Publicado no Clin Breast Cancer (2018)

Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from...

Por Smyth, L. M., Iyengar, N. M., Chen, M. F., Popper, S. M., Patil, S, Wasserheit-Lieblich, C., Argolo, D. F., Singh, J. C., Chandarlapaty, S, Sugarman, S. M., Comen, E. A., Drullinsky, P. R., Traina, T. A., Troso-Sandoval, T, Baselga, J, Norton, L, Hudis, C. A., Dang, C. T.
Publicado no Breast Cancer Res Treat (2016)

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Tria...

Por Freedman, Rachel A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J., Muss, H. B.
Publicado no Breast Cancer Res Treat (2016)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

Por Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
Publicado em 2014